Dapagliflozin Patient Satisfaction Survey

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

NCT00736879 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

NCT01392677 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

NCT00528879 ·Status: COMPLETED ·Phase: PHASE3

Effect of Dapagliflozin on Glycemic Variability

NCT02459353 ·Status: COMPLETED ·Phase: PHASE4

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

NCT00831779 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Dapagliflozin Taken Twice-daily

NCT01217892 ·Status: COMPLETED ·Phase: PHASE3

A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects

NCT00162305 ·Status: COMPLETED ·Phase: PHASE2

Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

NCT01439854 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

NCT01042977 ·Status: COMPLETED ·Phase: PHASE3

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

NCT00859898 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea

NCT00995787 ·Status: COMPLETED ·Phase: PHASE1

Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes

NCT03444584 ·Status: COMPLETED ·Phase: PHASE2

Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects

NCT00908271 ·Status: COMPLETED ·Phase: PHASE1

A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes

NCT07026968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Effects of Dapagliflozin in Normal Clinical Practice in T2D

NCT05418946 ·Status: UNKNOWN

A Real World Experience of Dapagliflozin in Type 2 Diabetes

NCT02966626 ·Status: COMPLETED

Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin

NCT00673231 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin

NCT03066830 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients

NCT02327039 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

NCT01606007 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers

NCT01156246 ·Status: COMPLETED ·Phase: PHASE1

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

NCT01095653 ·Status: COMPLETED ·Phase: PHASE3

Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

NCT05214573 ·Status: COMPLETED

Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety

NCT05915949 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients

NCT00680745 ·Status: COMPLETED ·Phase: PHASE3